David C Chan

Title: The Innovative Contributions of David C. Chan

Introduction

David C. Chan is a prominent inventor based in Arcadia, California. He has made significant contributions to the field of biomedical research, particularly in the study of neurodegenerative diseases. With a total of 10 patents to his name, Chan's work has had a profound impact on understanding and modeling conditions such as Parkinson's disease.

Latest Patents

One of Chan's latest patents is for a transgenic mouse that has a genome comprising a homozygous disruption of the endogenous MFN2 gene expression in dopaminergic neurons. This animal model serves as a valuable tool for studying Parkinson's disease, as the disruption of the Mfn2 gene leads to severe movement disorders due to the progressive degeneration of the nigrostriatal circuit. Another notable patent is for a Five-Helix protein, which includes the three N-helices and at least two of the three C-helices of the trimer-of-hairpin structure of HIV gp41. Additionally, he has developed a Six-Helix protein that encompasses all three N-helices and C-helices of the same structure, separated by linkers.

Career Highlights

Throughout his career, David C. Chan has worked at prestigious institutions such as the Whitehead Institute for Biomedical Research and the California Institute of Technology. His research has focused on innovative approaches to understanding complex biological systems and diseases.

Collaborations

Chan has collaborated with notable scientists, including Peter S. Kim and Deborah Fass, contributing to advancements in their respective fields.

Conclusion

David C. Chan's innovative work and patents have significantly advanced the understanding of neurodegenerative diseases and the development of potential therapeutic models. His contributions continue to influence the biomedical research community.